Successful treatment of pulmonary metastases from malignant melanoma with inhalation IL-2 therapy combined with DTIC;Therapie von lungenmetastasen des malignen melanoms mit inhalativem IL- 2

Hautarzt

Volumn 48, Issue 12, 1997, Pages 894-896

  Enk, Alexander H ^a   Nashan, Dorothee ^b   Knop, Jürgen ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Inhalation; Interleukin 2; Lung metastasis; Melanoma

Indexed keywords

DACARBAZINE; INTERLEUKIN 2;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COUGHING; DRUG RESPONSE; FEMALE; FEVER; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG METASTASIS; MALE; MELANOMA; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADULT; AGED; COMBINED MODALITY THERAPY; DACARBAZINE; FEMALE; HUMANS; INTERLEUKIN-12; LUNG NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; SKIN NEOPLASMS;

EID: 0031438991     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001050050681     Document Type: Article

References (10)

1. Balch CM, Houghton AN, Milton GW, Soong SJ (1992) Cutaneous melanoma: clinical management and treatment results world-wide. Lippincott, Philadelphia, pp 165-187
2. Garbe C, Büttner P, Bertz J, Burg G, d'Hoedt B, Drepper H, Guggenmoos-Holzmann I, Lechner W, Lippold A, Orfanos CE, Peters A, Rassner G, Stadler R, Stroebel W (1995) Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients. Cancer 75:2484-2491
3. Garbe C, Kreuser ED, Zouboulis CC, Stadler R, Orfanos CE (1992) Combined treatment of metastatic melanoma with interferons and cytotoxic drugs. Semin Oncol 19:63-69
4. Garbe C (1993) Chemotherapy and chemo-immunotherapy in disseminated malignant melanoma. Melanoma Res 3:291-299
5. Ho VC, Sober AJ (1990) Therapy of cutaneous melanoma: an update. J Am Acad Dermatol 22:159-176
6. Huland E (1992) Interleukin-2 by inhalation: local therapy for metastatic renal cell carcinoma. J Urol 147:344-348
7. Huland E (1994) Inhaled IL-2 in combination with low dose systemic IL-2 and interferon-α in patients with pulmonary metastatic renal-cell carcinoma: effectiveness and toxicity of mainly local treatment. J Cancer Res Clin Oncol 120:221-228
8. Orfanos CE, Jung HG, Rassner G, Wolff HH, Garbe C (1994) Stellungnahme und Empfehlungen der Kommission Malignes Melanom der Deutschen Dermatologischen Gesellschaft zur Diagnostik, Behandlung und Nachsorge des malignen Melanoms der Haut - Stand 1993/1994. Hautarzt 43:285-291
9. Rosenberg SA, Yang JC, Topalian SL (1994) Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high dose bolus interleukin-2. JAMA 271:907-914
10. Schadendorf D, Binting S, Henz-Czarnetzki B (1996) Prognose des primären und meta-stasierenden malignen Melanoms -Abschließende Auswertung des geschlossenen Patientenkollektivs an der Haut-klinik des Virchow Klinikums, Berlin, von 1981-1995. Haut Geschlechtskr 71:833-837